Examining Clinical Trial Participation for Small Cell Lung Cancer Patients

Launched by POWER LIFE SCIENCES INC. · Mar 3, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at why some small cell lung cancer patients find it hard to participate in clinical studies or complete them. The researchers want to understand the challenges faced by different groups of patients, so they can make future clinical trials easier and more accessible for everyone. By studying various demographic factors, they hope to identify trends that could improve the experience for patients with small cell lung cancer in future research.

To take part in this trial, participants need to be at least 18 years old and have a diagnosis of small cell lung cancer. They should be able to follow the study's schedule, including attending visits and undergoing tests. However, patients who have difficulty following medical advice, are pregnant or breastfeeding, or have certain other medical conditions may not be eligible. Since the study is not yet recruiting, interested individuals will need to wait for it to begin before applying.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed.
• • Participant has a diagnosis of small cell lung cancer.
• • Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
• Exclusion Criteria:
• • Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent.
• • Pregnant or lactating woman
• • Known medical condition that, in the investigator's opinion, would increase the risk associated with study participation or study drug(s) administration or interfere with the interpretation of safety results